Leading the life sciences industry
Discover the 150+ academic medical centers, commercial labs, incubators, accelerators, and programs and services leading life sciences in New York State.
Funding
Investing in innovation
Careers
Your future starts here
The Latest
2026 Upstate Capital Impact Exchange
The Upstate Capital Impact Exchange is a one-day convening of investors, fund managers, founders, policymakers, and regional leaders focused on how regions attract, deploy, and scale early- and later-stage capital. The program highlights New York State’s investment ecosystem as a national model for how institutional and public capital can catalyze private investment and regional growth.
Paid registration required.
Launch NY Introduces Technical Assistance Program Partners, Expanding Access to Professional Support for Startups
Funded by Empire State Development’s NY Ventures, the initiative provides no-cost, hands-on legal, accounting, and financial advisory services to high-growth startups.Qualifying life sciences and biotech start-ups can learn more here.
Apply Today: Isle of Man’s 2026 Innovation Challenge
Isle of Man will host their 4th annual innovation challenge to accelerate health and social care sectors. Applications for the 2026 cohort are due February 27, 2026 and final presentations scheduled for June 25, 2026.
Digital Health New York Releases 2026 Healthcare Innovation Report + DH100
Digital Health New York’s Healthcare Innovation Report analyzes the investment trends, opportunities and challenges in New York’s evolving digital health sector.
This issue features insights from 30+ founders, investors, providers and thought leaders. They discuss topics ranging from the founder-funder dynamic to the implementation of AI to predictions for 2026. And not to be missed – we present the 2026 Digital Health 100 (DH100), a list of the most exciting and innovative health startups in the New York region.
NewYorkBio Appoints 2026 Board of Directors
NewYorkBIO appointed the 2026 Board of Directors representing various sectors and share a commitment to advancing the growth of New York’s statewide life science industry.
The new class of leaders includes Andrew Lam of Ally Bridge Group,Theresa Mazzullo of Excell Partners, Monica Shaw of Bristol Myers Squibb and Julia Nanyi Zhao, PhD of BioLabs@NYU.
The following board members were reelected to serve another three-year term: Rana Al-Hallaq llaq of Pfizer Ventures, Matt Badalucco of Merck, Dawn Bell of Kardigan.Bio, Lis Leiderman, MD,
Robert Van Nostrand a Veteran Biotech CFO, Manan Shah of 1619 Advisors and Alan Tamarelli of Cooley LLP.
LIFE SCIENCES IN NEW YORK
Where science and opportunity come together
New York’s life science sector has attracted unprecedented investment, expanded research clusters across the state, and nurtured the growth of early-stage companies.
70,000
LIFE SCIENCES JOBS
25%
CLINICAL TRIALS IN THE U.S.
60%
PHARMACEUTICAL HEADQUARTERS